mTOR Inhibitors: a myth, a cure for cancer or something in between?

G Wong, J R Chapman, J C Craig

Research output: Contribution to journalEditorial

3 Citations (Scopus)

Abstract

This editorial summarizes the current evidence and the authors' perspective regarding the role of mTOR inhibitors and cancer in kidney transplant recipients. See article by Campbell et al on page 1146.
Original languageEnglish
Pages (from-to)1075-1076
Number of pages2
JournalAmerican Journal of Transplantation
Volume12
Issue number5
DOIs
Publication statusPublished - Apr 2012

Keywords

  • cancer
  • kidney transplantation
  • Mammalian target of rapamycin (mTOR) inhibitors

Fingerprint Dive into the research topics of 'mTOR Inhibitors: a myth, a cure for cancer or something in between?'. Together they form a unique fingerprint.

  • Cite this